Company Overview of Athena Biotechnologies, Inc.
Athena Biotechnologies, Inc., a biotechnology company, provides chemicals and enzymes for pharmaceuticals, agrichemicals, and industrial and therapeutic enzyme markets. It offers natural product libraries from various sources, including plant roots and non-culturable bacteria. The company provides biosource plant root and bacterial libraries, which contains compounds that are chemically diverse and biologically active; industrial enzymes; and therapeutic enzymes. Athena Biotechnologies was formerly known as VerdiZyme, Inc. The company was founded in 2005 and is based in Newark, Delaware.
1090 Elkton Road
Stine-Haskell Research Center
Newark, DE 19714
Founded in 2005
Key Executives for Athena Biotechnologies, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Athena Biotechnologies, Inc., please visit www.athenabio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.